retatrutide 50 mg RO-3R 50mg - Research Grade Retatrutide (Reta GLP-3) - 99%+

Participants with obesity and knee osteoarthritis experienced average weight loss of 71.2 pounds alongside substantial relief from osteoarthritis pain

Also note that abruptly stopping GLP-1 medication is not recommended

[DOI] [PubMed] [Google Scholar] 83.Eslam M., Sarin S.K., Wong V.W.-S., Fan J.-G., Kawaguchi T., Ahn S.H., Zheng M.-H., Shiha G., Yilmaz Y., Gani R., et al

Nominal Group Technique This study used the NGT method to gain insight into the adoption of the combined use of GLP1-RAs and SGLT2is in everyday clinical practice regarding the main topics of the scoping review: metabolic control, weight change, major cardiovascular events, hospitalizations for heart failure, major renal events, and adverse effects